The NEW STANDARD in
IgE allergy testing

We are solving challenges faced today in laboratories and clinical practices with the NOVEOS System, the first technological breakthrough in routine allergy diagnostics in 20 years.

DOING MORE WITH LESS REDUCES:

  • Quantity Not Sufficient (QNS) errors

  • Re-sampling

  • Trauma for hard-to-draw patients

ENHANCES PATIENT CARE
e.g. PEDIATRIC PATIENTS

FR_NOVEOS_squares3.jpg

Lowest sample volume per test

​1/10th of other methods

FR_NOVEOS_squares.jpg

Microparticle Allergy Testing

Accurate & Precise

CUTTING-EDGE IMMUNOCHEMISTRY

  • High sensitivity and excellent low-end precision 

  • Large reagent lot sizes

  • Use of standardized extracts when available

A NEW STANDARD OF ASSAYS DESIGNED FOR ACCURATE ALLERGY TEST RESULTS

ACCURATE & PRECISE RESULTS

  • Assays designed to limit interference from Biotin, IgG/IgG4 or solid-phase related cross-reactive carbohydrate determinants (CCD)
     

  • Reliable results for better clinical decisions

IMPROVES THE QUALITY

OF LIFE FOR PATIENTS

FR_NOVEOS_squares2.jpg

Insignificant Interference

CCD, Biotin & IgG / IgG4 

FR_NOVEOS_squares4.jpg

Laboratory Efficiency

Overcoming Challenges

NOVEOS SOFTWARE

  • Intuitive icon-driven user interface

  • Touchscreen and swipe able navigation

  • Real-time results reporting

  • High capacity database

  • Flexible quality control

  • Operator can easily search any result

ACCESS INFORMATION WITH EASE